


Initiator Pharma Revenue
Biotechnology Research • Copenhagen, Capital Region of Denmark, Denmark • 1-10 Employees
Initiator Pharma revenue & valuation
| Annual revenue | $684,440 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $2,200,000 |
| Total funding | $2,100,000 |
Key Contacts at Initiator Pharma
Peter Holm
Member Board Of Directors
Christina Guldberg
Senior Director Clinical Development And Outcomes Research Rare Diseases
Company overview
| Headquarters | Copenhagen, Capital Region of Denmark, Denmark |
| Phone number | +4561260035 |
| Website | |
| SIC | 283 |
| Founded | 2016 |
| Employees | 1-10 |
| Socials |
About Initiator Pharma
Initiator Pharma A/S, a clinical-stage pharma company developing innovative drugs targeting key unmet medical needs within the central and peripheral nervous system. Initiator Pharma is listed on First North Stockholm, Sweden (INIT). Initiator Pharma’s pipeline consists of three clinical programs – the clinical programs IP2018 and pudafensine for treatment of erectile dysfunction of psychogenic and organic origin, respectively, and a neuropathic pain program based on pudafensine. Furthermore, Initiator Pharma has recent announce that the drug candidates, pudafensine and IP2018, have shown significant efficacy in preclinical models for Female Sexual Dysfunction (FSD).
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Initiator Pharma has 1 employees across 1 departments.
Departments
Number of employees
Initiator Pharma Tech Stack
Discover the technologies and tools that power Initiator Pharma's digital infrastructure, from frameworks to analytics platforms.
CDN
JavaScript libraries
JavaScript libraries
Tag managers
Cookie compliance
Programming languages
Miscellaneous
Cookie compliance
Blogs
Miscellaneous
Hosting
Maps
Frequently asked questions
4.8
40,000 users



